Related Experiment Video
Updated: Apr 18, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
From transcriptional regulation to drugging the cancer epigenome
1Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115 USA.
Abstract:
Jay Bradner discusses the opportunities and challenges for the study and therapeutic targeting of the cancer epigenome, as well as innovative approaches to drug discovery.
Insights
This discussion covers the cancer epigenome, exploring challenges and opportunities in its study and therapeutic targeting. It also highlights innovative strategies for cancer drug discovery.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- The cancer epigenome presents complex challenges and opportunities for therapeutic intervention.
- Understanding epigenetic modifications is crucial for developing novel cancer treatments.
Purpose of the Study:
- To discuss the current landscape of cancer epigenome research.
- To explore innovative approaches in cancer drug discovery targeting epigenetic mechanisms.
Main Methods:
- Review of current research and therapeutic strategies.
- Discussion of emerging drug discovery paradigms.
Main Results:
- Identification of key challenges in targeting the cancer epigenome.
- Highlighting promising innovative approaches for drug development.
Conclusions:
- The cancer epigenome offers significant therapeutic potential.
- Innovative drug discovery is essential for realizing this potential in cancer treatment.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Treatment Resistant Cancers
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Mitogens and the Cell Cycle

